Researcher.Life Logo

Health Economics Review : Impact Factor & More

eISSN: 2191-1991pISSN: 2191-1991
JournalOpen Access

Key Metrics

CiteScore
2.9
SNIP
1.01
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Health Economics Review

Health Economics Review Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2190 | USD 2590 | GBP 1890
Publication Time13
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 13
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Health Economics Review ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Health Economics Review

Economic burden of blindness and moderate to severe vision impairment in Slovenia.
  • 25 Apr 2026
  • Health economics review
Cost-utility of first-line dostarlimab plus carboplatin-paclitaxel compared with placebo for patients with pA/rEC: a partitioned survival analysis.
  • 23 Apr 2026
  • Health economics review
Costs and cost-effectiveness of type 2 diabetes management in Sub-Saharan Africa: a systematic review.
  • 22 Apr 2026
  • Health economics review
The economic burden of COVID-19 undervaccination: costs of hospitalisation, ICU admission, and death in Scotland.
  • 21 Apr 2026
  • Health economics review
Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review.
  • 18 Apr 2026
  • Health economics review
Economic evaluation of automated scalp cooling systems for breast cancer patients in Spain.
  • 17 Apr 2026
  • Health economics review
Economic burden of blindness and moderate to severe vision impairment in Slovenia.
  • 25 Apr 2026
  • Health economics review
Cost-utility of first-line dostarlimab plus carboplatin-paclitaxel compared with placebo for patients with pA/rEC: a partitioned survival analysis.
  • 23 Apr 2026
  • Health economics review
Costs and cost-effectiveness of type 2 diabetes management in Sub-Saharan Africa: a systematic review.
  • 22 Apr 2026
  • Health economics review
The economic burden of COVID-19 undervaccination: costs of hospitalisation, ICU admission, and death in Scotland.
  • 21 Apr 2026
  • Health economics review
Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review.
  • 18 Apr 2026
  • Health economics review
Economic evaluation of automated scalp cooling systems for breast cancer patients in Spain.
  • 17 Apr 2026
  • Health economics review

FAQs on Health Economics Review